Clinical Information

The measurement of AMH is used to distinguish between women with AFC (antral follicle count) values > 15 (high ovarian reserve) and women with AFC values ≤ 15 (normal or diminished ovarian reserve), as an aid in the assessment of the ovarian reserve in women presenting to fertility clinics. This assay should be used in conjunction with other clinical and laboratory findings, such as AFC, before starting fertility therapy. This assay should NOT be used for monitoring women undergoing controlled ovarian stimulation in an Assisted Reproduction Technology program. Specimens for AMH levels should be drawn on days 2-4 of the menstrual cycle. The performance of the assay has not been established in women with the following endocrine or metabolic disorders: diabetes, pituitary, adrenal, pancreas, liver and kidney disease, hypothalamic disorders, high prolactin, congenital adrenal hyperplasia, premature ovarian failure, and premature ovarian insufficiency. The following drugs may interfere with this test: Cetrotide, Ovitrelle, Endometrin, and Follistatin: do not use this test to analyze samples from patients who have received one or more of these products within one to two weeks of testing.